Cargando…
Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Recent evidence suggests that oxidative stress may play a role in myocarditis. Here, we investigated whether olmesartan, an AT(...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048845/ https://www.ncbi.nlm.nih.gov/pubmed/21383952 |
_version_ | 1782199193020923904 |
---|---|
author | Sukumaran, Vijayakumar Watanabe, Kenichi Veeraveedu, Punniyakoti T. Gurusamy, Narasimman Ma, Meilei Thandavarayan, Rajarajan A. Lakshmanan, Arun Prasath Yamaguchi, Ken'ichi Suzuki, Kenji Kodama, Makoto |
author_facet | Sukumaran, Vijayakumar Watanabe, Kenichi Veeraveedu, Punniyakoti T. Gurusamy, Narasimman Ma, Meilei Thandavarayan, Rajarajan A. Lakshmanan, Arun Prasath Yamaguchi, Ken'ichi Suzuki, Kenji Kodama, Makoto |
author_sort | Sukumaran, Vijayakumar |
collection | PubMed |
description | Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Recent evidence suggests that oxidative stress may play a role in myocarditis. Here, we investigated whether olmesartan, an AT(1)R antagonist protects against experimental autoimmune myocarditis (EAM) by suppression of oxidative stress, endoplasmic reticulum (ER) stress and inflammatory cytokines. EAM was induced in Lewis rats by immunization with porcine cardiac myosin, were divided into two groups and treated with either olmesartan (10 mg/kg/day) or vehicle for a period of 21 days. Myocardial functional parameters measured by hemodynamic and echocardiographic analyses were significantly improved by the treatment with olmesartan compared with those of vehicle-treated rats. Treatment with olmesartan attenuated the myocardial mRNA expressions of proinflammatory cytokines, [Interleukin (IL)-1β, monocyte chemoattractant protein-1, tumor necrosis factor-α and interferon-γ)] and the protein expression of tumor necrosis factor-α compared with that of vehicle-treated rats. Myocardial protein expressions of AT(1)R, NADPH oxidase subunits (p47phox, p67phox, gp91phox) and the expression of markers of oxidative stress (3-nitrotyrosine and 4-hydroxy-2-nonenal), and the cardiac apoptosis were also significantly decreased by the treatment with olmesartan compared with those of vehicle-treated rats. Furthermore, olmesartan treatment down-regulated the myocardial expressions of glucose regulated protein-78, growth arrest and DNA damage-inducible gene, caspase-12, phospho-p38 mitogen-activated protein kinase (MAPK) and phospho-JNK. These findings suggest that olmesartan protects against EAM in rats, at least in part via suppression of oxidative stress, ER stress and inflammatory cytokines. |
format | Text |
id | pubmed-3048845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-30488452011-03-07 Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis Sukumaran, Vijayakumar Watanabe, Kenichi Veeraveedu, Punniyakoti T. Gurusamy, Narasimman Ma, Meilei Thandavarayan, Rajarajan A. Lakshmanan, Arun Prasath Yamaguchi, Ken'ichi Suzuki, Kenji Kodama, Makoto Int J Biol Sci Research Paper Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Recent evidence suggests that oxidative stress may play a role in myocarditis. Here, we investigated whether olmesartan, an AT(1)R antagonist protects against experimental autoimmune myocarditis (EAM) by suppression of oxidative stress, endoplasmic reticulum (ER) stress and inflammatory cytokines. EAM was induced in Lewis rats by immunization with porcine cardiac myosin, were divided into two groups and treated with either olmesartan (10 mg/kg/day) or vehicle for a period of 21 days. Myocardial functional parameters measured by hemodynamic and echocardiographic analyses were significantly improved by the treatment with olmesartan compared with those of vehicle-treated rats. Treatment with olmesartan attenuated the myocardial mRNA expressions of proinflammatory cytokines, [Interleukin (IL)-1β, monocyte chemoattractant protein-1, tumor necrosis factor-α and interferon-γ)] and the protein expression of tumor necrosis factor-α compared with that of vehicle-treated rats. Myocardial protein expressions of AT(1)R, NADPH oxidase subunits (p47phox, p67phox, gp91phox) and the expression of markers of oxidative stress (3-nitrotyrosine and 4-hydroxy-2-nonenal), and the cardiac apoptosis were also significantly decreased by the treatment with olmesartan compared with those of vehicle-treated rats. Furthermore, olmesartan treatment down-regulated the myocardial expressions of glucose regulated protein-78, growth arrest and DNA damage-inducible gene, caspase-12, phospho-p38 mitogen-activated protein kinase (MAPK) and phospho-JNK. These findings suggest that olmesartan protects against EAM in rats, at least in part via suppression of oxidative stress, ER stress and inflammatory cytokines. Ivyspring International Publisher 2011-02-11 /pmc/articles/PMC3048845/ /pubmed/21383952 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. |
spellingShingle | Research Paper Sukumaran, Vijayakumar Watanabe, Kenichi Veeraveedu, Punniyakoti T. Gurusamy, Narasimman Ma, Meilei Thandavarayan, Rajarajan A. Lakshmanan, Arun Prasath Yamaguchi, Ken'ichi Suzuki, Kenji Kodama, Makoto Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis |
title | Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis |
title_full | Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis |
title_fullStr | Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis |
title_full_unstemmed | Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis |
title_short | Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis |
title_sort | olmesartan, an at(1) antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048845/ https://www.ncbi.nlm.nih.gov/pubmed/21383952 |
work_keys_str_mv | AT sukumaranvijayakumar olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT watanabekenichi olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT veeraveedupunniyakotit olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT gurusamynarasimman olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT mameilei olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT thandavarayanrajarajana olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT lakshmananarunprasath olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT yamaguchikenichi olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT suzukikenji olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis AT kodamamakoto olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis |